CN114868891A - Nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases - Google Patents

Nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases Download PDF

Info

Publication number
CN114868891A
CN114868891A CN202210304121.XA CN202210304121A CN114868891A CN 114868891 A CN114868891 A CN 114868891A CN 202210304121 A CN202210304121 A CN 202210304121A CN 114868891 A CN114868891 A CN 114868891A
Authority
CN
China
Prior art keywords
cardiovascular
parts
patients
cerebrovascular diseases
root
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202210304121.XA
Other languages
Chinese (zh)
Inventor
林峰
杨杰
杨健
焦润江
刘桂琴
王海月
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dayiseng Technology Beijing Co ltd
Original Assignee
Dayiseng Technology Beijing Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dayiseng Technology Beijing Co ltd filed Critical Dayiseng Technology Beijing Co ltd
Priority to CN202210304121.XA priority Critical patent/CN114868891A/en
Publication of CN114868891A publication Critical patent/CN114868891A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases, which comprises the following raw materials in parts by weight: 1-2 parts of kudzu root, 0.5-0.7 part of bovine bone peptide, 0.2-0.4 part of Chinese yam, 0.2-0.4 part of tartary buckwheat, 0.2-0.3 part of whey protein, 1-2 parts of wild kudzu root, 0.1-0.3 part of sweet potato, 0.2-0.3 part of fish oil, 0.2-0.3 part of soybean phospholipid, 0.1-0.3 part of highland barley and 0.12-0.14 part of oat. The DHA and EPA have heart protection effects, including arrhythmia resistance and thrombus resistance; simultaneously, the composition can reduce blood pressure, increase endothelial function and resist atherosclerosis. Experiments prove that DHA and other substances in the vascular endothelial cells have strong antioxidant effect; ingestion of DHA.

Description

Nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases
Technical Field
The invention relates to the technical field of cardiovascular and cerebrovascular diseases, in particular to a nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases.
Background
A large number of epidemiological studies and large-scale prospective clinical studies have demonstrated that there is a close correlation between factors including dietary imbalances (lack of vegetables and fruits in the diet, excessive amounts of meat and fat, excessive salt intake, heavy alcohol consumption), lack of exercise, smoking and mental stress, plasma cholesterol levels, etc., and cardiovascular and cerebrovascular diseases. According to the characteristics of cardiovascular and cerebrovascular diseases, the theory of traditional Chinese medicine is applied, and the medicine can be preferably used as food, and the food is endowed with medicinal souls, so that the food and the medicine can be eaten in the middle of the treatment. The Chinese medicine theory of homology of medicine and food has been developed since ancient times. This theory holds that: many foods are both food and pharmaceuticals. In the period of Tang dynasty, the book "Huangdi Nei Jing Taisu" is written: food is taken on empty stomach, and medicine is taken by patients, reflecting the idea of homology of medicine and food. Tang.Sun Si far away has highlighted: "Xiandiping" for releasing the symptoms and diseases is called as good job. "persuade people to eat food for nourishing for the day. The food therapy is a source of life, has nutritive value, and can prevent and treat diseases, build body and prolong life. It can make eaters enjoy delicious food, and in the enjoyment, make their bodies obtain nourishing and disease-improving effects. Based on the purpose of controlling or reducing the risk factors of cardiovascular diseases and achieving the purpose of preventing and relieving the risk of cardiovascular and cerebrovascular diseases, the invention provides a nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases.
Disclosure of Invention
The invention aims to provide a nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases, so as to solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme:
a nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases comprises the following raw materials in parts by weight:
1-2 parts of kudzu root, 0.5-0.7 part of bovine bone peptide, 0.2-0.4 part of Chinese yam, 0.2-0.4 part of tartary buckwheat, 0.2-0.3 part of lactalbumin, 1-2 parts of wild kudzu root, 0.1-0.3 part of sweet potato, 0.2-0.3 part of fish oil, 0.2-0.3 part of soybean lecithin, 0.1-0.3 part of highland barley, 0.12-0.14 part of oat, 0.1-0.3 part of brown rice, 0.14-0.16 part of carrot, 0.14-0.16 part of tomato, 0.1-0.3 part of potassium citrate, 0.1-0.3 part of sugar alcohol, 0.1-0.3 part of xylitol, 0.11-0.13 part of sophora flower bud, 0.07-0.09 part of lotus seed, 0.07-0.06 part of gordon euryale seed, 0.07-0.06 part of semen cassiae, 0.1-0.3 part of pumpkin, 0.04 part of red cabbage root, 0.07-0.3 part of celery root, 0.3 part of red cabbage, 0.3 part of black bean sprout, 0.3, Walnut peptide 0.04-0.06 and stevioside 0.002-0.004.
Preferably, the nutrient formula for the patients with the cardiovascular and cerebrovascular diseases comprises the following raw materials in parts by weight:
1.2 to 2 portions of kudzu root, 0.6 to 0.7 portion of bovine bone peptide, 0.3 to 0.4 portion of yam, 0.3 to 0.4 portion of tartary buckwheat, 0.22 to 0.3 portion of lactalbumin, 1.2 to 2 portions of wild kudzu root, 0.2 to 0.3 portion of sweet potato, 0.22 to 0.3 portion of fish oil, 0.21 to 0.3 portion of soybean lecithin, 0.2 to 0.3 portion of highland barley, 0.13 to 0.14 portion of oat, 0.2 to 0.3 portion of brown rice, 0.15 to 0.16 portion of carrot, 0.15 to 0.16 portion of tomato, 0.2 to 0.3 portion of potassium citrate, 0.2 to 0.3 portion of erythritol, 0.2 to 0.3 portion of xylitol, 0.12 to 0.13 portion of sophora flower bud, 0.08 to 0.09 portion of lotus seed, 0.06 to 0.09 portion of gordon euryale seed, 0.08 to 0.09 portion of coix seed, 0.09 to 0.09 portion of cassia seed, 0.05 portion of pumpkin, 0.05 to 0.05 portion of purple cabbage, 0.05 portion of celery root, 0.05 portion of black cabbage, 0.3 portion of black bean, 0.2 to 0.3 portion of black bean, 0.3 portion of black bean sprout, 0.3 portion of black bean, 0.3 to 0.3 portion of black bean, 0.3 portion of black bean, 0.3 portion of black bean, walnut peptide 0.05-0.06 parts, stevioside 0.003-0.004 parts.
Preferably, the nutrient formula for the patients with the cardiovascular and cerebrovascular diseases comprises the following raw materials in parts by weight:
1.5 parts of kudzuvine root, 0.6 part of beef bone peptide, 0.3 part of Chinese yam, 0.3 part of tartary buckwheat, 0.25 part of lactalbumin, 1.5 parts of wild kudzuvine root, 0.2 part of sweet potato, 0.25 part of fish oil, 0.25 part of soybean phospholipid, 0.2 part of highland barley, 0.13 part of oat, 0.2 part of brown rice, 0.15 part of carrot, 0.15 part of tomato, 0.2 part of potassium citrate, 0.2 part of erythritol, 0.2 part of xylitol, 0.12 part of sophora flower bud, 0.08 part of lotus seed, 0.08 part of gordon euryale seed, 0.08 part of coix seed, 0.2 part of cassia seed, 0.08 part of pumpkin, 0.2 part of beetroot, 0.08 part of hawthorn, 0.05 part of red cabbage, 0.05 part of celery, 0.05 part of walnut peptide and 0.003 part of stevioside.
Preferably, the kudzuvine root is obtained by washing and draining the kudzuvine root, then placing the washed and drained kudzuvine root into a pulverizer for pulverizing, sieving the pulverized kudzuvine root with 100-200 meshes, finally sending the pulverized kudzuvine root into an extraction tank for extraction treatment, and obtaining the kudzuvine root after the extraction.
Preferably, the rotation speed of the milling powder is 100-.
Preferably, the extraction processing power is 100-.
Preferably, the extraction processing power is 250W, and the extraction time is 30 min.
The invention has the following effects:
key nutrition supplement and reinforcement for patients with cardiovascular and cerebrovascular diseases
1. Relationship between cardiovascular and cerebrovascular diseases and proteins
Protein is an important nutrient element and a composition component of a human body, and most of disabled and semi-disabled old people with cardiovascular and cerebrovascular diseases are in a negative nitrogen balance state, so that the demand on the protein is increased. Research shows that the incidence of hypoalbuminemia of patients with high-protein enteral nutrition is obviously lower than that of patients with standard enteral nutrition; and the survival rate in a short period is higher than that of a patient with standard enteral nutrition.
1.1 Effect of walnut peptide on cardiovascular and cerebrovascular diseases
Studies have shown that walnut peptides can ameliorate lipopolysaccharide-induced memory disorders by ameliorating inflammatory reactions and oxidative stress in the brain [4 ]. Through a positioning navigation test, the escape latency and the distance of a model group mouse for searching a target platform are much longer than those of a control group mouse, which indicates that the mouse injected with lipopolysaccharide cannot accurately position and memorize the target platform; and the escape latency and distance of walnut peptide-dosed mice to find the target platform are significantly reduced. Through a space exploration test, the swimming time and the target distance of the model group are observed to be less than those of the control group, and the swimming time of the walnut peptide injected mice in a target area is obviously increased. The walnut peptide can improve the mouse memory disorder induced by lipopolysaccharide.
1.2 Effect of bovine bone peptide on cardiovascular and cerebrovascular diseases
Researches find that the biological active peptide from animal protein has stronger blood pressure lowering effect. The small molecular peptide has different biological activities, such as immunoregulation, blood pressure reduction, blood sugar reduction, blood fat reduction, antibiosis, anti-aging, antioxidation, anticancer, antimicrobial, antitoxin, bone density increase, bone toughness improvement and the like. Experiments prove that the inhibition effect of the bovine bone peptide on the activity of angiotensin converting enzyme in vivo can obviously reduce the systolic pressure of spontaneous hypertension rats [8 ]. The bovine bone peptide has a certain treatment effect on spontaneous hypertension of rats.
1.3 Effect of whey protein on cardiovascular and cerebrovascular diseases
Abdominal obesity is associated with postprandial elevated Triglycerides (TG), an independent risk factor for cardiovascular disease. There are studies showing that whey protein can lower postprandial blood glucose. The research shows that when the mice fed with high-fat diet are treated by whey protein, the fasting blood sugar content is obviously reduced, the plasma insulin content is reduced, and the plasma adiponectin level is obviously increased. Therefore, the lactalbumin has certain effects of reducing blood sugar and plasma insulin content and increasing plasma adiponectin.
2. Soybean phospholipid for improving cardiovascular and cerebrovascular diseases
Experiments prove that the soybean phospholipid mixture has a good lipid-lowering effect on the over-normal blood lipid, and particularly has a remarkable effect on the reduction of triglyceride; the arteriosclerosis index is also reduced. The soybean phospholipids comprise different physiologically active components such as Phosphatidylcholine (PC), Phosphatidylinositol (PI), Phosphatidylethanolamine (PE), Phosphatidylserine (PA), etc. Phosphatidylcholine is a raw material for the synthesis of lipoproteins, which are the mobile form of fat; meanwhile, the lecithin has hydrophilicity and lipophilicity in chemical structure, can emulsify cholesterol into superfine particles, and the superfine emulsified cholesterol particles can be utilized by tissues through blood vessel walls without increasing the cholesterol in blood plasma and reducing the deposition of the cholesterol on the inner walls of the blood vessels. The mechanism of the action of soybean phospholipids for regulating blood lipid is probably to reduce blood lipid by increasing the movement of Triglyceride (TG) and emulsifying and removing serum Total Cholesterol (TC). The soybean lecithin has the functions of regulating blood fat and resisting arteriosclerosis.
3. Effect of fish oil (DHA/EPA) on cardiovascular and cerebrovascular diseases
DHA and EPA have cardioprotective, including antiarrhythmic, antithrombotic effects; simultaneously, the composition can reduce blood pressure, increase endothelial function and resist atherosclerosis. Experiments prove that DHA and other substances in the vascular endothelial cells have strong antioxidant effect; the intake of DHA can effectively reduce the risk of atherosclerosis and cardiovascular diseases; meanwhile, DHA has the functions of reducing the content of triglyceride in blood, preventing sudden cardiac death and preventing the recurrence of coronary heart disease.
4. Action of dietary fiber on cardiovascular and cerebrovascular diseases
Besides the well-known constipation preventing and treating effects, the dietary fiber can also inhibit the absorption of cholesterol and bile acid by human bodies. Constipation can induce sudden death due to acute heart failure, arrhythmia, etc., and also easily induce psychological problems such as anxiety, etc. Research shows that the dietary fiber can obviously reduce blood pressure, total cholesterol, low-density lipoprotein cholesterol, blood sugar and glycosylated hemoglobin level.
Celery is the first choice for treating hypertension and complications thereof, is clinically effective on primary hypertension, gestational hypertension and climacteric hypertension, and has an auxiliary treatment effect on angiosclerosis. Researches find that apigenin shows certain activity on an LXR receptor model and can effectively improve the sensitivity of the FXR receptor model, so that further sensitization of atherosclerosis is delayed, and the occurrence probability of cardiovascular diseases is reduced. In addition, by remembering that the LXR model increases the excretion of cholesterol from the liver, thereby reducing the absorption of cholesterol by the small intestine and thus modulating blood lipid levels.
Anthocyanins are present in purple cabbage. Anthocyanins are demonstrated to have a role in regulating lipid metabolism. Anthocyanins can improve dyslipidemia, treat diabetes, and reduce serum low density lipoprotein cholesterol and triglyceride levels. The tomato contains abundant synthetic substances beneficial to health, wherein 9-oxo-linoleic acid can increase the content of fatty acid in blood, improve the metabolism capability of liver lipid and effectively prevent vascular diseases.
Lycopene exists in fructus Lycopersici Esculenti, and has effect in preventing cardiovascular disease and cerebrovascular disease. The carrot contains rich beta-carotene, and researches show that the beta-carotene can obviously improve the whole lipid metabolism level of the old people, and the total cholesterol level of blood plasma and the cholesterol level of low-density lipoprotein are reduced.
Beetroot contains high dietary nitrate and has been shown to improve cardiovascular function. The soluble fiber and total fiber content of the highland barley are higher than those of other cereal crops, and the highland barley is rich in vitamin B, vitamin C, calcium, phosphorus, iron and other trace elements, and has the characteristics of high protein, high fiber, high vitamin, low fat, low sugar and the like.
The highland barley can reduce blood sugar and improve various complications caused by diabetes. A large number of animal experiment researches prove that the oat extract has the effect of improving cardiovascular and cerebrovascular basic lesions, and particularly has various symptoms such as hyperlipidemia, hypertension, vascular lesions and the like.
Oats contain beta-glucan, a soluble dietary fiber, and are effective in lowering total cholesterol and low density lipoprotein cholesterol levels.
The brown rice has effects of reducing cholesterol and triglyceride, and preventing cardiovascular disease and cerebrovascular disease. The main functional components of the brown rice comprise inositol, oryzanol, octacosanol, rice bran polysaccharide, rice bran fiber, mineral substances, gamma-aminobutyric acid and the like. Inositol has therapeutic effects on angiosclerosis and hypercholesterolemia; oryzanol can reduce the content of serum total cholesterol and triglyceride; octacosanol can strengthen heart function and reduce blood pressure; the rice bran polysaccharide can reduce cholesterol, regulate blood lipid, and reduce blood sugar; the rice bran fiber can adjust blood fat concentration and blood sugar; gamma-aminobutyric acid can reduce blood fat.
5. Relationship between cardiovascular and cerebrovascular diseases and saccharides
The compound saccharide is taken to promote enterokinesia and accelerate cholesterol discharge, and is beneficial to preventing and treating hypertension. Xylitol, erythrose and stevioside belong to natural low-calorie sweeteners, limit total energy and are very beneficial to the treatment of hypertension.
6. Influence of microelements on cardiovascular and cerebrovascular diseases
High sodium low potassium diet is an important environmental factor causing hypertension and cardiovascular and cerebrovascular damage. The research shows that the potassium deficiency can cause the artery wall of the hypertension patient to be thickened, thereby increasing the probability of the hypertension patient to have cardiovascular and cerebrovascular events. The potassium supplement treatment can reduce blood pressure, protect blood vessel and tissue organ, and prevent damage of artery wall.
Modern medical research result of homology of medicine and food
1. Kudzu root
The kudzu root is sweet and pungent in taste and cool in nature, enters lung and stomach channels, and has the effects of relieving muscles and reducing fever, promoting eruption, promoting the production of body fluid to quench thirst, and invigorating yang to arrest diarrhea. The Shennong herbal classic originally records that the root of kudzu vine is the traditional medicinal and edible Chinese medicinal material with the effects of quenching thirst, body heat, vomiting, various kinds of arthralgia, activating yin qi and removing various kinds of toxicity, and has long history in China and the reputation of 'thousand-year ginseng'. Modern pharmacological research shows that the effective components of the kudzu root extract can reduce blood pressure, treat cerebral infarction, resist atherosclerosis, resist myocardial ischemia and the like, and can effectively improve cardiovascular and cerebrovascular diseases.
Research shows that the kudzuvine root has good effects on treating cardiovascular and cerebrovascular diseases such as myocardial protection, blood pressure reduction, blood fat reduction and the like. Puerarin components in kudzu root may affect signal pathways such as AMPK/mammalian target protein (mTOR) signal pathway, protein kinase C epsilon (protein kinase epsilon, PKC epsilon) signal pathway and the like to improve cardiovascular diseases. Puerarin can relieve cerebral edema and damage of right permanent middle cerebral artery occlusion (pMCAO) model rat postoperative blood-cerebrospinal fluid barrier (BBB), reduce cerebral infarction volume, and up-regulate claudin-5 expression and inhibit MMP-9 expression [31 ]. Puerarin has wide pharmacological actions of regulating blood fat, improving endothelial function, inhibiting smooth muscle cell proliferation, resisting inflammation, inhibiting foam cell formation, inhibiting platelet aggregation and the like, and has obvious treatment effect on atherosclerosis [33 ]. The pueraria flavonid has obvious effects of dilating coronary vessels, promoting cerebral circulation and improving local mild cerebral circulation disorder, and can also improve arrhythmia caused by acute myocardial ischemia by influencing the permeability of cell membranes to sodium, potassium, calcium and other ions.
2. Tartary buckwheat
The tartary buckwheat is bitter in taste, mild in nature and cold, and has the effects of benefiting strength, keeping spirit, benefiting ears and eyes, descending qi, relaxing intestines and invigorating stomach. Compendium of materia Medica: descending qi, widening intestine, grinding, removing food retention, relieving heat, swelling and wind-pain. Remove the stagnation of white turbidity and blood, and the accumulation of spleen and diarrhea. The tartary buckwheat is one of natural health-care foods integrating nutrition, health care and medical treatment in the world at present, is called as a food treasure with dual purposes of medicine and food, contains various nutritional ingredients and chemical ingredients beneficial to human bodies, and has various efficacies of reducing blood sugar, reducing blood fat, reducing blood pressure, improving blood vessel microcirculation and the like.
Researches show that the flavone compounds extracted from the tartary buckwheat seeds can inhibit the increase of Triglyceride (TG) level in the blood serum of mice after 3 hours of gastric administration of olive oil and inhibit the increase of TG level of the mice fed with high-fat high-cholesterol feed. The tartary buckwheat bran extract can reduce serum total cholesterol level and reduce cholesterol and triglyceride level of hyperlipidemic rats. Has good effect of reducing blood fat.
3. Chinese yam
The yam is mild in nature and sweet in taste, warmly nourishes without sudden, slightly fragrant without dryness, enters spleen, lung and kidney meridians, is a good medicine for tonifying spleen and nourishing stomach, and promoting fluid production and benefiting lung, and is also a traditional health food. It is listed as the top grade in Shen nong Ben Cao Jing, which is recorded in Shen nong's herbal Jing and is called "the formula mainly for impairment of middle energizer, tonifying deficiency and winning, removing pathogenic factors of cold and heat, tonifying middle energizer and replenishing qi". Rhizoma Dioscoreae has effects of invigorating spleen, invigorating lung, invigorating kidney, and replenishing vital essence; modern pharmacological experiments show that the Chinese yam has obvious effects of reducing blood sugar, reducing blood fat and the like.
The rhizoma Dioscoreae polysaccharide has effects of lowering blood sugar and reducing blood lipid by regulating glycolipid metabolism related enzyme activity, coordinating antioxidation, and improving insulin sensitivity. The rhizoma Dioscoreae polysaccharide can effectively reduce Fasting Blood Glucose (FBG) and Glucose Tolerance (GT) of diabetic mice, lower blood sugar level and inhibit diabetic complications; can improve the survival rate of islet cells and has an effective effect on improving platelet function [37 ]. In addition, it can also reduce blood sugar (GLU), Total Cholesterol (TC), Triglyceride (TG) and low density lipoprotein cholesterol (LDL-C) concentration in diabetic mice, relieve weight loss, and regulate glycolipid metabolism disorder of diabetic mice. The Chinese yam contains abundant trace elements, mucin, vitamins and the like, and the substances can effectively prevent the cardiovascular system from generating fat deposition, thereby keeping the elasticity of blood vessels. And dopamine existing in rhizoma Dioscoreae can dilate blood vessel, thereby improving blood circulation. The Chinese yam has the obvious functions of reducing blood sugar and blood fat, regulating glycolipid metabolic disturbance, keeping blood vessel elasticity and improving blood circulation.
4. Sweet potato
The sweet potato contains rich trace elements, particularly potassium element, and can promote the discharge of excessive sodium in blood and the balance of mineral substance levels of organisms, thereby achieving the effect of assisting in reducing blood pressure. The sweet potato has multiple nutrients which interact with each other, and can play a role in assisting in reducing blood pressure, protecting heart and cerebral vessels and preventing stroke. As pointed out in journal articles of the United states of America "prevention", it has been found that potassium-rich foods such as sweet potatoes can reduce the risk of stroke by 20%. The anthocyanin in the sweet potato can obviously reduce the blood sugar amount in a normal blood sugar animal model and can play a role in controlling hyperglycemia in a diabetes animal model established by high saturated fat. Meanwhile, the dietary fiber contained in the sweet potato can delay the rise of the postprandial blood sugar. Selenium element in sweet potato can play a role in assisting in regulating blood sugar. The sweet potato has the effects of assisting in reducing blood pressure, regulating blood sugar and the like.
5. Sophora flower bud
Sophora flower bud, being bitter in taste and slightly cold, enters liver and large intestine meridians. Has effects of cooling blood, stopping bleeding, clearing liver-fire, etc. Can be used for treating hematochezia, hemorrhoid hemorrhage, metrorrhagia, hematemesis, liver heat with conjunctival congestion, dysentery with blood, and dizziness. Researches show that the effective components of the sophora flower bud have the activities of resisting platelet aggregation and the like, and have good effects of improving myocardial circulation, reducing blood fat, softening blood vessels and resisting depression.
The flavonoids are the main active ingredients in the sophora flower bud, and mainly comprise rutin, quercetin and the like. Rutin has effects of improving microcirculation and reducing capillary fragility, and is mainly used for adjuvant treatment of diabetes, hypertension and hyperglycemia. Experiments show that the alcohol extract of the sophora flower bud has better activity of reducing uric acid and reducing blood sugar; can promote the differentiation of 3T3-L1 preadipocytes and reduce the blood sugar of type II diabetic mice. Flos Sophorae Immaturus has antidepressant effect. Neizhifu adopts a classical anxiety model, a mouse diving platform experiment and a light and dark box experiment to observe the protection effect of quercetin in the sophora flower bud on a mouse, and finds that the anxiolytic activity of the sophora flower bud is possibly related to increasing the content of gamma aminobutyric acid and glutamic acid in the brain.
6. Cassia seed
Semen Cassiae has sweet and bitter taste and slight cold property, enters liver channel and large intestine channel, and has effects of removing liver fire, improving eyesight, and loosening bowel to relieve constipation. Pharmacological research shows that the medicine has the functions of reducing blood fat, blood pressure, blood sugar, etc. The cassia seed is rich in resources in China, is listed as one of medicinal and edible traditional Chinese medicine products by the national ministry of health at present, has high medicinal value, and is widely applied to clinical formulas, Chinese patent medicine production and health-care food.
Pharmacological experiment research shows that the cassia seed alcohol extract has obvious effect of reducing Total Cholesterol (TC) and Triglyceride (TG) of serum of mice and rats in hyperlipaemia models, and in addition, soluble fiber in cassia seed can also reduce the serum and liver fat content of rats with high cholesterol diet. The semen Cassiae water extract can reduce blood lipid by influencing endogenous metabolites such as amino acids and cholesterol. The aurantio-obtusin is an important anthraquinone component in the cassia seed, can obviously reduce cholesterol, triglyceride and low-density lipoprotein cholesterol of hyperlipidemic rats, and is also a main effective component in the cassia seed for controlling the blood fat level of patients. The semen cassiae anthraquinone glycoside can remarkably reduce the systolic pressure of the tail artery of the rat with the renal hypertension, reduce the contents of urine albumin and beta 2-microglobulin in the urine of the rat, and improve the renal injury induced by the hypertension, and meanwhile, the semen cassiae anthraquinone glycoside can also remarkably inhibit the cardiac hypertrophy caused by the renal hypertension and improve the ventricular diastolic function. Semen Cassiae has effects of reducing blood lipid, lowering blood pressure, inhibiting cardiac hypertrophy caused by renal hypertension, and improving ventricular diastolic function.
7. Hawthorn fruit
The hawthorn is sour and sweet in taste and slightly warm in nature; enters spleen, stomach and liver channels, and has effects of resolving food stagnation, invigorating stomach, activating qi-flowing, removing blood stasis, eliminating turbid pathogen and reducing blood lipid. Researches on chemical components and pharmacological effects of the hawthorn show that the hawthorn can protect human vascular endothelial cells, and particularly has obvious curative effect on cardiovascular diseases.
Anthocyanidin in fructus crataegi is the main component of blood pressure lowering effect, and when flavonoid, oligomeric procyanidin and triterpenic acid extract are administered intravenously to various animals for a long time, it can be observed that anesthetized animals are in dose-dependent hypotension, and the blood pressure lowering effect is mainly caused by peripheral vasodilatation. The total flavone separated from folium crataegi can reduce arrhythmia, and reduce the burst of Lactate Dehydrogenase (LDH) after myocardial injury caused by ischemia and anoxia. In addition, total flavonoids enhance endogenous oxygen, scavenge the system and reduce lipid peroxidation, suggesting that they have a role in relieving myocardial ischemia. Meanwhile, the research finds that the total flavone in the hawthorn leaves obviously reduces the serum Total Cholesterol (TC) and Triacylglycerol (TG) levels in a high cholesterol rabbit model. The fructus crataegi has effects of lowering blood pressure, improving arrhythmia, relieving myocardial ischemia, and reducing blood lipid.
8. Lotus seed
The lotus seed is sweet and astringent in taste and neutral in nature, and has the effects of tonifying spleen, stopping diarrhea, stopping leukorrhagia, tonifying kidney, arresting seminal emission, nourishing heart and soothing nerves, and the spleen, kidney and heart meridians are entered. Can be used for treating diarrhea due to spleen deficiency, leukorrhagia, spermatorrhea, and myocardial insomnia. Modern pharmacological research shows that the compound has the function of reducing blood sugar.
The lotus extract and alkaloid components are proved to have obvious effects of protecting heart and cerebral vessels and resisting atherosclerosis. Neferine can be used for preventing and treating atherosclerosis and restenosis. Lalitha and the like research the protection effect of neferine on isoproterenol-induced myocardial infarction, and find that the neferine can restore biochemical indexes and lipid content to near normal level. The semen Nelumbinis can protect cardiovascular system and prevent atherosclerosis and myocardial infarction induced by isoproterenol.
9. Gorgon fruit
Semen euryales is sweet and astringent in taste and neutral in nature, has the effects of invigorating spleen, relieving diarrhea, tonifying kidney, arresting seminal emission, eliminating dampness and stopping leukorrhagia, and is used for treating nocturnal emission, spermatorrhea, enuresis, frequent micturition, spleen deficiency and chronic diarrhea, whitish and turbid urine and leukorrhagia. Modern pharmacological research shows that the gorgon fruit has the biological activities of reducing blood sugar, resisting myocardial ischemia, resisting hyperlipidemia and the like.
Studies have found that the polysaccharide component of Gordon euryale seed can reverse the symptoms of alloxan-induced weight loss in hyperglycemic mice, improve oral glucose tolerance, increase hepatic glycogen content and Glucokinase (GCK) activity, regulate the mRNA expression of GCK in the liver, and lower blood glucose by increasing serum insulin levels. In addition, the gorgon fruit aqueous extract has the function of improving the post-ischemic heart function and reducing the degree of myocardial ischemia-reperfusion injury of rats, and is probably related to that the active component glycolipid compound of the gorgon fruit can induce the expression of TRP-32 and thioredoxin-1. Semen euryales can improve ventricular function after ischemia, reduce myocardial infarction area, and has cardioprotective effect.
10. Coix seed
The coix seed has sweet and light taste and cool nature, enters spleen, stomach and lung channels, and has the effects of promoting diuresis, invigorating spleen, relaxing muscles and tendons, removing arthralgia, clearing heat, expelling pus, removing toxic substances and resolving hard mass. Modern pharmacological research shows that the coix seed has pharmacological activities of reducing blood sugar, reducing blood pressure and the like.
Researches show that the abdominal cavity administration of a certain dose of coix seed polypeptide can inhibit the blood sugar rise of mice caused by epinephrine with remarkable effect. In addition, the coix seed polypeptide can reduce the leptin content in the blood serum of a rat and simultaneously increase the adiponectin content in the blood serum, so that the coix seed polysaccharide can obviously reduce the body mass, improve physical signs and reduce fasting blood glucose and the blood glucose level after 2h of meal for a rat glycolipid metabolic disorder model induced by clozapine. The coix seed protein has obvious effect of reducing serum insulin level and resistance index and can effectively improve insulin sensitivity. The Coicis semen also contains coixol, and phytosterol, wherein the coixol has effects of reducing blood lipid, lowering blood pressure, protecting liver and reducing nerve injury, and the phytosterol is cholesterol compound, is structural component of plant cell membrane, and can reduce cholesterol absorption. The production method comprises the steps of carrying out hydrolysis on coix seed alcohol-soluble protein by simulating gastrointestinal environment such as plum-Siberian solomonseal rhizome, and the like, and intragastrically administering the generated biological peptide to a hypertensive mouse, wherein the result shows that the blood pressure of the mouse is remarkably reduced, and the blood pressure reducing effect is realized by inhibiting angiotensin converting enzyme. Coicis semen has effects of lowering blood sugar, regulating glycolipid metabolism disorder, reducing blood lipid, and lowering blood pressure.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below with reference to specific embodiments, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The nutrient formula applicable to the cardiovascular and cerebrovascular patients comprises the following raw materials in parts by weight:
1-2 parts of kudzu root, 0.5-0.7 part of bovine bone peptide, 0.2-0.4 part of Chinese yam, 0.2-0.4 part of tartary buckwheat, 0.2-0.3 part of lactalbumin, 1-2 parts of wild kudzu root, 0.1-0.3 part of sweet potato, 0.2-0.3 part of fish oil, 0.2-0.3 part of soybean lecithin, 0.1-0.3 part of highland barley, 0.12-0.14 part of oat, 0.1-0.3 part of brown rice, 0.14-0.16 part of carrot, 0.14-0.16 part of tomato, 0.1-0.3 part of potassium citrate, 0.1-0.3 part of sugar alcohol, 0.1-0.3 part of xylitol, 0.11-0.13 part of sophora flower bud, 0.07-0.09 part of lotus seed, 0.07-0.06 part of gordon euryale seed, 0.07-0.06 part of semen cassiae, 0.1-0.3 part of pumpkin, 0.04 part of red cabbage root, 0.07-0.3 part of celery root, 0.3 part of red cabbage, 0.3 part of black bean sprout, 0.3, Walnut peptide 0.04-0.06 and stevioside 0.002-0.004.
The nutrient formula suitable for the cardiovascular and cerebrovascular patients comprises the following raw materials in parts by weight:
1.2 to 2 portions of kudzu root, 0.6 to 0.7 portion of bovine bone peptide, 0.3 to 0.4 portion of yam, 0.3 to 0.4 portion of tartary buckwheat, 0.22 to 0.3 portion of lactalbumin, 1.2 to 2 portions of wild kudzu root, 0.2 to 0.3 portion of sweet potato, 0.22 to 0.3 portion of fish oil, 0.21 to 0.3 portion of soybean lecithin, 0.2 to 0.3 portion of highland barley, 0.13 to 0.14 portion of oat, 0.2 to 0.3 portion of brown rice, 0.15 to 0.16 portion of carrot, 0.15 to 0.16 portion of tomato, 0.2 to 0.3 portion of potassium citrate, 0.2 to 0.3 portion of erythritol, 0.2 to 0.3 portion of xylitol, 0.12 to 0.13 portion of sophora flower bud, 0.08 to 0.09 portion of lotus seed, 0.06 to 0.09 portion of gordon euryale seed, 0.08 to 0.09 portion of coix seed, 0.09 to 0.09 portion of cassia seed, 0.05 portion of pumpkin, 0.05 to 0.05 portion of purple cabbage, 0.05 portion of celery root, 0.05 portion of black cabbage, 0.3 portion of black bean, 0.2 to 0.3 portion of black bean, 0.3 portion of black bean sprout, 0.3 portion of black bean, 0.3 to 0.3 portion of black bean, 0.3 portion of black bean, 0.3 portion of black bean, walnut peptide 0.05-0.06 parts, stevioside 0.003-0.004 parts.
The nutrient formula suitable for the cardiovascular and cerebrovascular patients comprises the following raw materials in parts by weight:
1.5 parts of kudzuvine root, 0.6 part of beef bone peptide, 0.3 part of Chinese yam, 0.3 part of tartary buckwheat, 0.25 part of lactalbumin, 1.5 parts of wild kudzuvine root, 0.2 part of sweet potato, 0.25 part of fish oil, 0.25 part of soybean phospholipid, 0.2 part of highland barley, 0.13 part of oat, 0.2 part of brown rice, 0.15 part of carrot, 0.15 part of tomato, 0.2 part of potassium citrate, 0.2 part of erythritol, 0.2 part of xylitol, 0.12 part of sophora flower bud, 0.08 part of lotus seed, 0.08 part of gordon euryale seed, 0.08 part of coix seed, 0.2 part of cassia seed, 0.08 part of pumpkin, 0.2 part of beetroot, 0.08 part of hawthorn, 0.05 part of red cabbage, 0.05 part of celery, 0.05 part of walnut peptide and 0.003 part of stevioside.
The kudzu vine root of the embodiment is prepared by washing and draining kudzu vine root, then grinding the kudzu vine root in a grinder, sieving the ground kudzu vine root by a sieve of 100 meshes and 200 meshes, finally sending the ground kudzu vine root into an extraction tank for extraction treatment, and obtaining the kudzu vine root after the extraction is finished.
The rotation speed of the milled powder in the embodiment is 100-500 r/min.
The extraction processing power of the embodiment is 100-400W, and the extraction time is 25-35 min.
The extraction processing power of this example was 250W, and the extraction time was 30 min.
Example 1:
the nutrient formula applicable to the cardiovascular and cerebrovascular patients comprises the following raw materials in parts by weight:
1 part of kudzu root, 0.2 part of beef bone peptide, 0.2 part of Chinese yam, 0.2 part of tartary buckwheat, 0.2 part of lactalbumin, 1 part of kudzu root, 0.1 part of sweet potato, 0.2 part of fish oil, 0.2 part of soybean phospholipid, 0.1 part of highland barley, 0.12 part of oat, 0.1 part of brown rice, 0.14 part of carrot, 0.15 part of tomato, 0.2 part of potassium citrate, 0.2 part of erythritol, 0.2 part of xylitol, 0.12 part of sophora flower bud, 0.08 part of lotus seed, 0.08 part of gorgon fruit, 0.08 part of coix seed, 0.2 part of cassia seed, 0.08 part of pumpkin, 0.2 part of beetroot, 0.08 part of hawthorn, 0.05 part of red cabbage, 0.05 part of celery, 0.05 part of walnut peptide and 0.003 part of stevioside.
The root of kudzu vine of this embodiment adopts washing, dripdrying for the root of kudzu vine, then places the rubbing powder in the rubbing crusher in, crosses 100 meshes, sends into at last and draws the processing in extracting the jar, draws the end, obtains the root of kudzu vine.
The rotational speed of the milled powder in this example was 100 r/min.
The extraction processing power of this example was 100W, and the extraction time was 25 min.
Example 2:
the nutrient formula applicable to the cardiovascular and cerebrovascular patients comprises the following raw materials in parts by weight:
1.5 parts of kudzuvine root, 0.6 part of beef bone peptide, 0.3 part of Chinese yam, 0.3 part of tartary buckwheat, 0.25 part of lactalbumin, 1.5 parts of wild kudzuvine root, 0.2 part of sweet potato, 0.25 part of fish oil, 0.25 part of soybean phospholipid, 0.2 part of highland barley, 0.13 part of oat, 0.2 part of brown rice, 0.15 part of carrot, 0.15 part of tomato, 0.2 part of potassium citrate, 0.2 part of erythritol, 0.2 part of xylitol, 0.12 part of sophora flower bud, 0.08 part of lotus seed, 0.08 part of gordon euryale seed, 0.08 part of coix seed, 0.2 part of cassia seed, 0.08 part of pumpkin, 0.2 part of beetroot, 0.08 part of hawthorn, 0.05 part of red cabbage, 0.05 part of celery, 0.05 part of walnut peptide and 0.003 part of stevioside.
The kudzu vine root of the embodiment is prepared by washing and draining kudzu vine root, then grinding the kudzu vine root in a grinder, sieving the ground kudzu vine root by a sieve of 100 meshes and 200 meshes, finally sending the ground kudzu vine root into an extraction tank for extraction treatment, and obtaining the kudzu vine root after the extraction is finished.
The rotational speed of the milled powder in this example was 300 r/min.
The extraction processing power of this example was 250W, and the extraction time was 30 min.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.

Claims (7)

1. A nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases is characterized by comprising the following raw materials in parts by weight:
1-2 parts of kudzu root, 0.5-0.7 part of bovine bone peptide, 0.2-0.4 part of Chinese yam, 0.2-0.4 part of tartary buckwheat, 0.2-0.3 part of lactalbumin, 1-2 parts of wild kudzu root, 0.1-0.3 part of sweet potato, 0.2-0.3 part of fish oil, 0.2-0.3 part of soybean lecithin, 0.1-0.3 part of highland barley, 0.12-0.14 part of oat, 0.1-0.3 part of brown rice, 0.14-0.16 part of carrot, 0.14-0.16 part of tomato, 0.1-0.3 part of potassium citrate, 0.1-0.3 part of sugar alcohol, 0.1-0.3 part of xylitol, 0.11-0.13 part of sophora flower bud, 0.07-0.09 part of lotus seed, 0.07-0.06 part of gordon euryale seed, 0.07-0.06 part of semen cassiae, 0.1-0.3 part of pumpkin, 0.04 part of red cabbage root, 0.07-0.3 part of celery root, 0.3 part of red cabbage, 0.3 part of black bean sprout, 0.3, Walnut peptide 0.04-0.06 parts, stevioside 0.002-0.004 parts.
2. The nutrient formula applicable to patients with cardiovascular and cerebrovascular diseases according to claim 1, wherein the nutrient formula applicable to patients with cardiovascular and cerebrovascular diseases comprises the following raw materials in parts by weight:
1.2 to 2 portions of kudzu root, 0.6 to 0.7 portion of bovine bone peptide, 0.3 to 0.4 portion of yam, 0.3 to 0.4 portion of tartary buckwheat, 0.22 to 0.3 portion of lactalbumin, 1.2 to 2 portions of wild kudzu root, 0.2 to 0.3 portion of sweet potato, 0.22 to 0.3 portion of fish oil, 0.21 to 0.3 portion of soybean lecithin, 0.2 to 0.3 portion of highland barley, 0.13 to 0.14 portion of oat, 0.2 to 0.3 portion of brown rice, 0.15 to 0.16 portion of carrot, 0.15 to 0.16 portion of tomato, 0.2 to 0.3 portion of potassium citrate, 0.2 to 0.3 portion of erythritol, 0.2 to 0.3 portion of xylitol, 0.12 to 0.13 portion of sophora flower bud, 0.08 to 0.09 portion of lotus seed, 0.06 to 0.09 portion of gordon euryale seed, 0.08 to 0.09 portion of coix seed, 0.09 to 0.09 portion of cassia seed, 0.05 portion of pumpkin, 0.05 to 0.05 portion of purple cabbage, 0.05 portion of celery root, 0.05 portion of black cabbage, 0.3 portion of black bean, 0.2 to 0.3 portion of black bean, 0.3 portion of black bean sprout, 0.3 portion of black bean, 0.3 to 0.3 portion of black bean, 0.3 portion of black bean, 0.3 portion of black bean, walnut peptide 0.05-0.06 parts, stevioside 0.003-0.004 parts.
3. The nutrient formula applicable to patients with cardiovascular and cerebrovascular diseases according to claim 1, wherein the nutrient formula applicable to patients with cardiovascular and cerebrovascular diseases comprises the following raw materials in parts by weight:
1.5 parts of kudzuvine root, 0.6 part of beef bone peptide, 0.3 part of Chinese yam, 0.3 part of tartary buckwheat, 0.25 part of lactalbumin, 1.5 parts of wild kudzuvine root, 0.2 part of sweet potato, 0.25 part of fish oil, 0.25 part of soybean phospholipid, 0.2 part of highland barley, 0.13 part of oat, 0.2 part of brown rice, 0.15 part of carrot, 0.15 part of tomato, 0.2 part of potassium citrate, 0.2 part of erythritol, 0.2 part of xylitol, 0.12 part of sophora flower bud, 0.08 part of lotus seed, 0.08 part of gordon euryale seed, 0.08 part of coix seed, 0.2 part of cassia seed, 0.08 part of pumpkin, 0.2 part of beetroot, 0.08 part of hawthorn, 0.05 part of red cabbage, 0.05 part of celery, 0.05 part of walnut peptide and 0.003 part of stevioside.
4. The nutrient formula for patients with cardiovascular and cerebrovascular diseases as claimed in claim 1, wherein the radix Puerariae is prepared by washing radix Puerariae with water, draining, pulverizing in a pulverizer, sieving with 100-200 mesh sieve, and extracting in an extraction tank.
5. The nutrient formulation for patients with cardiovascular and cerebrovascular diseases according to claim 4, wherein the rotational speed of the milled powder is 100-500 r/min.
6. The nutrient formulation for patients with cardiovascular and cerebrovascular diseases as defined in claim 4, wherein the extraction treatment power is 100-.
7. The nutrient formula for patients with cardiovascular and cerebrovascular diseases according to claim 6, wherein the extraction treatment power is 250W, and the extraction time is 30 min.
CN202210304121.XA 2022-03-26 2022-03-26 Nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases Pending CN114868891A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210304121.XA CN114868891A (en) 2022-03-26 2022-03-26 Nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210304121.XA CN114868891A (en) 2022-03-26 2022-03-26 Nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases

Publications (1)

Publication Number Publication Date
CN114868891A true CN114868891A (en) 2022-08-09

Family

ID=82668118

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210304121.XA Pending CN114868891A (en) 2022-03-26 2022-03-26 Nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases

Country Status (1)

Country Link
CN (1) CN114868891A (en)

Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101579121A (en) * 2009-03-18 2009-11-18 北京惠中铭捷生物科技有限公司 Nutritional food with hpyerglycemic function and preparation method thereof
CN101744170A (en) * 2009-12-25 2010-06-23 成都大学 Tartary buckwheat eight ingredient porridge suitable for patients with diabetes and preparing method thereof
CN103610144A (en) * 2013-11-30 2014-03-05 大连润扬科技发展有限公司 Walnut powder with blood glucose reduction effect and preparation method thereof
CN103637348A (en) * 2013-12-05 2014-03-19 王丽华 Pueraria powder medicinal granule for preventing arteriosclerosis and preparation method thereof
CN105077236A (en) * 2015-07-23 2015-11-25 汉济生物科技（武汉）有限公司 Highland barley composite special dietary nutritional powder with auxiliary blood glucose reducing function and preparation method thereof
CN105685818A (en) * 2016-01-26 2016-06-22 福建古瑞森生物科技有限公司 Food composition suitable for hypertension hyperlipidemia hyperglycemia population and preparation method thereof
CN105995993A (en) * 2016-05-26 2016-10-12 阮佟娜 Food composition applicable to diabetic and preparation method thereof
CN106174474A (en) * 2016-07-05 2016-12-07 郑州和正生物科技有限公司 A kind of it is applicable to the special dietary seafood that Patients with Cardiovascular/Cerebrovascular Diseases is edible
CN107048422A (en) * 2017-04-17 2017-08-18 通泰心脑健康管理有限公司 A kind of nutritional preparation of patients with cerebral apoplexy rehabilitation
CN107348331A (en) * 2017-06-12 2017-11-17 金梅 A kind of alimentation composition for Impaired Glucose Regulation and preparation method thereof
CN107485031A (en) * 2017-07-08 2017-12-19 吴江贤 A kind of full nutrient formulation of five cereals food containing collagen peptide
CN107897905A (en) * 2017-12-06 2018-04-13 刘文广 A kind of hypoglycemic nutrition powder and its preparation method and application
CN107912688A (en) * 2017-11-30 2018-04-17 抚州市鑫汇隆生物科技有限公司 A kind of hypoglycemic, lowering blood pressure and blood fat grain dust
CN108719727A (en) * 2018-06-06 2018-11-02 唐山肽景堂生物科技有限公司 A kind of solid beverage and preparation method thereof of conditioning cerebral thrombus peptide compounding
CN109965270A (en) * 2019-04-03 2019-07-05 上海奥医生物医药科技有限公司 A kind of blood pressure lowering tailored version clinical nutrition formula and preparation method thereof
CN110771880A (en) * 2019-11-08 2020-02-11 国家半干旱农业工程技术研究中心 Blood sugar-reducing quinoa meal replacement powder and preparation process thereof
CN111374312A (en) * 2018-12-29 2020-07-07 广东澳思瑞雅健康美容生物科技有限公司 Health food for supplementing comprehensive nutrition and easy absorption
CN112931741A (en) * 2019-12-23 2021-06-11 上海赋康健康管理有限公司 Dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health

Patent Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101579121A (en) * 2009-03-18 2009-11-18 北京惠中铭捷生物科技有限公司 Nutritional food with hpyerglycemic function and preparation method thereof
CN101744170A (en) * 2009-12-25 2010-06-23 成都大学 Tartary buckwheat eight ingredient porridge suitable for patients with diabetes and preparing method thereof
CN103610144A (en) * 2013-11-30 2014-03-05 大连润扬科技发展有限公司 Walnut powder with blood glucose reduction effect and preparation method thereof
CN103637348A (en) * 2013-12-05 2014-03-19 王丽华 Pueraria powder medicinal granule for preventing arteriosclerosis and preparation method thereof
CN105077236A (en) * 2015-07-23 2015-11-25 汉济生物科技（武汉）有限公司 Highland barley composite special dietary nutritional powder with auxiliary blood glucose reducing function and preparation method thereof
CN105685818A (en) * 2016-01-26 2016-06-22 福建古瑞森生物科技有限公司 Food composition suitable for hypertension hyperlipidemia hyperglycemia population and preparation method thereof
CN105995993A (en) * 2016-05-26 2016-10-12 阮佟娜 Food composition applicable to diabetic and preparation method thereof
CN106174474A (en) * 2016-07-05 2016-12-07 郑州和正生物科技有限公司 A kind of it is applicable to the special dietary seafood that Patients with Cardiovascular/Cerebrovascular Diseases is edible
CN107048422A (en) * 2017-04-17 2017-08-18 通泰心脑健康管理有限公司 A kind of nutritional preparation of patients with cerebral apoplexy rehabilitation
CN107348331A (en) * 2017-06-12 2017-11-17 金梅 A kind of alimentation composition for Impaired Glucose Regulation and preparation method thereof
CN107485031A (en) * 2017-07-08 2017-12-19 吴江贤 A kind of full nutrient formulation of five cereals food containing collagen peptide
CN107912688A (en) * 2017-11-30 2018-04-17 抚州市鑫汇隆生物科技有限公司 A kind of hypoglycemic, lowering blood pressure and blood fat grain dust
CN107897905A (en) * 2017-12-06 2018-04-13 刘文广 A kind of hypoglycemic nutrition powder and its preparation method and application
CN108719727A (en) * 2018-06-06 2018-11-02 唐山肽景堂生物科技有限公司 A kind of solid beverage and preparation method thereof of conditioning cerebral thrombus peptide compounding
CN111374312A (en) * 2018-12-29 2020-07-07 广东澳思瑞雅健康美容生物科技有限公司 Health food for supplementing comprehensive nutrition and easy absorption
CN109965270A (en) * 2019-04-03 2019-07-05 上海奥医生物医药科技有限公司 A kind of blood pressure lowering tailored version clinical nutrition formula and preparation method thereof
CN110771880A (en) * 2019-11-08 2020-02-11 国家半干旱农业工程技术研究中心 Blood sugar-reducing quinoa meal replacement powder and preparation process thereof
CN112931741A (en) * 2019-12-23 2021-06-11 上海赋康健康管理有限公司 Dietary food for assisting in reducing blood fat and blood pressure and maintaining cardiovascular and cerebrovascular health

Similar Documents

Publication Publication Date Title
CN104432084B (en) A kind of conditioning powder and its production and use
CN101695376B (en) Health-care food for preventing diabetes
CN107296949A (en) Integration of drinking and medicinal herbs compound formulation and its preparation method and application
CN103054113B (en) Composite fruit-vegetable juice beverage with blood sugar decreasing effect
CN102511869B (en) Thickened red jujube ginger pulp
CN110447902B (en) Composition with weight-losing effect
CN105942498A (en) Functional nutritional food compounds with diabetes-treating effects and preparation methods thereof
CN108719984B (en) Meal replacement nutrition bar for gout population and preparation method thereof
CN1742927A (en) Medicinal tablet made from fruit of Chinese wolfberry and spica Mori and its preparing process
CN109329930A (en) A kind of composition and preparation method thereof for promoting uric acid to reduce
CN103734392A (en) Fructus cannabis-black tartary buckwheat tea health beverage and preparation method thereof
CN106937741A (en) A kind of degreasing linseed meal cancer-resisting health slimming method and preparation method thereof
CN101455379A (en) Nutrient food suitable of diabetic and preparation method thereof
CN111096416A (en) Diet-depriving composition for weight-losing meal replacement and preparation method thereof
CN1742971A (en) Instant preparation of Fructus sea semen Amomi and hawthorn and preparing process
CN104106828A (en) Solid beverage for reducing blood glucose
CN101243883B (en) Health food with function of reducing blood sugar and its preparation
CN107050349A (en) A kind of cream taste of toxin expelling promoting blood circulation and its preparation method and application
CN110638038A (en) Medical formula nutritional meal replacement powder for controlling hyperglycemia and preparation method thereof
CN1742970A (en) Fructus citri sarcodactylis tablet
CN105056005A (en) Medicinal and edible composition capable of reducing fat and losing weight
CN114868891A (en) Nutrient formula suitable for patients with cardiovascular and cerebrovascular diseases
CN112970992A (en) Solid beverage suitable for diabetes patients and preparation method thereof
CN105638961A (en) Dark green tea composition with ramie leaves and preparation method thereof
CN110226721A (en) A kind of composition with auxiliary hyperglycemic function

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination